Pharmacogenomics of Hypertension: A Genome‐Wide, Placebo‐Controlled Cross‐Over Study, Using Four Classes of Antihypertensive Drugs-Reference-Cited by-同舟云学术

Pharmacogenomics of Hypertension: A Genome‐Wide, Placebo‐Controlled Cross‐Over Study, Using Four Classes of Antihypertensive Drugs

Published:2015-01-05 Issue:1 Volume:4 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Hiltunen Timo P.¹,Donner Kati M.²,Sarin Antti‐Pekka²³,Saarela Janna²,Ripatti Samuli²⁴⁵,Chapman Arlene B.⁶⁷,Gums John G.⁸⁹,Gong Yan⁸,Cooper‐DeHoff Rhonda M.⁸¹⁰,Frau Francesca¹¹,Glorioso Valeria¹²,Zaninello Roberta¹²,Salvi Erika¹¹,Glorioso Nicola¹²,Boerwinkle Eric¹³¹⁴,Turner Stephen T.¹⁵,Johnson Julie A.⁸,Kontula Kimmo K.¹

Affiliation:

1. Department of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

2. Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland

3. Public Health Genomics Unit, National Institute for Health and Welfare, University of Helsinki, Helsinki, Finland

4. Department of Public Health, Hjelt Institute, University of Helsinki, Helsinki, Finland

5. Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom

6. Mayo Clinic, Rochester, MN

7. Department of Medicine, Renal Division, Emory University School of Medicine, Atlanta, GA

8. Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, University of Florida, Gainesville, FL

9. Department of Community Health and Family Medicine, Gainesville, FL

10. Department of Medicine, Gainesville, FL

11. Department of Health Sciences, Genomics and Bioinformatics Unit, University of Milan and Filarete Foundation, Milan, Italy

12. Hypertension and Related Disease Centre, AOU‐University of Sassari, Sassari, Italy

13. University of Florida, Gainesville, FL

14. Human Genetics and Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX

15. Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Measuring the Global Burden of Disease

2. US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008

3. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

4. Genetic basis of blood pressure and hypertension

5. Genes for blood pressure: an opportunity to understand hypertension

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseases;European Journal of Pharmacology;2024-10

2. Fabrication of a novel MoB/BiOCl photocatalyst for losartan and Escherichia coli removal;Catalysis Today;2024-03

3. Genetic and phenotypic frequency distribution of ACE, ADRB1, AGTR1, CYP2C9*3, CYP2D6*10, CYP3A5*3, NPPA and factors associated with hypertension in Chinese Han hypertensive patients;Medicine;2023-03-10

4. Sensitive detection of single-nucleotide polymorphisms by conjugated polymers for personalized treatment of hypertension;Science Translational Medicine;2023-03-08

5. Decompression Mechanism of Radish Seed in Prehypertension Rats through Integration of Transcriptomics and Metabolomics Methods;Evidence-Based Complementary and Alternative Medicine;2023-01-31